Today
@today·5M subscribers·54.4K videos
Weight-Loss Pill Study Compares Effectiveness to Injectables
Posted
September 18, 2025
Views
1,544
Likes
13
Engagement
0.84%
September 18, 2025
1,544
13
0.84%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:59Now PlayingNearly 12% of Americans have used GLP-1s like Ozempic and Wegovy, which require a weekly injection. A new study from Novo Nordisk offers encouraging news in the race to develop a pill version of the medications. NBC’s medical contributor Dr. Natalie Azar joins TODAY to break down the results of the study, which includes the pill’s effectiveness, side effects and shares when it is expected to become available.
» Subscribe to TODAY
TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website
Find TODAY on Facebook
Follow TODAY on Twitter
Follow TODAY on Instagram
» Stream TODAY All Day
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#weightloss #health #ozempic
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
